Effects of different doses of methylprednisolone on clinical outcomes in patients with severe community-acquired pneumonia: a study protocol for a randomized controlled trial

BACKGROUND: The specific use of methylprednisolone in severe community-acquired pneumonia (SCAP) has not yet formed a consensus. It is not clear whether the clinical efficacy of methylprednisolone in SCAP is dose-dependent, and how to balance the best efficacy with the least complications. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Shukun, Wang, Hongye, Liu, Jian, Qiao, Lujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123754/
https://www.ncbi.nlm.nih.gov/pubmed/35598005
http://dx.doi.org/10.1186/s13063-022-06404-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123754/
https://www.ncbi.nlm.nih.gov/pubmed/35598005
http://dx.doi.org/10.1186/s13063-022-06404-8

Ejemplares similares